BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential
Company plans to initiate SERENITY At-Home pivotal Phase 3 safety trial with 120 mcg dose following recent meeting with FDA […]
Company plans to initiate SERENITY At-Home pivotal Phase 3 safety trial with 120 mcg dose following recent meeting with FDA […]
BOSTON and LONDON, April 22, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims […]
MONTVALE, N.J., April 22, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today published its 2023 Sustainability Report, highlighting the […]
TALLAHASSEE, Fla., April 22, 2024 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable […]
RESTON, Va., April 22, 2024 (GLOBE NEWSWIRE) — Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating […]
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving […]
ALMATY, Kazakhstan, April 22, 2024 (GLOBE NEWSWIRE) — Joint Stock Company Kaspi.kz (“Kaspi.kz”, “we”, or the “Company”) (Nasdaq: KSPI) which […]
DALLAS, April 22, 2024 (GLOBE NEWSWIRE) — Beneficient (Nasdaq: BENF), a technology-enabled platform providing liquidity, primary capital, and related trust […]